Unlocking the strategic value of freedom to operate

46 minute read
22 October 2020

For any organization invested in research and development, IP landscaping and Freedom to Operate (FTO) analysis can serve as a vital roadmap as you bring your product to life – and finally to market.

Join LifeSciences BC and members of Gowling WLG's Life Sciences Group along with Ben Thiede of Stemcell Technologies, as together they explore strategies for managing IP risks and opportunities in an innovative life sciences enterprise.

NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.